Evidence map›Paper›PMID 34239116›Full record

ArticleNature biomedical engineering2021

Single-cell-resolved differentiation of human induced pluripotent stem cells into pancreatic duct-like organoids on a microwell chip.

Sandra Wiedenmann, Markus Breunig, Jessica Merkle, Christine von Toerne, Tihomir Georgiev, Michel Moussus, Lucas Schulte, Thomas Seufferlein, Michael Sterr, Heiko Lickert and 6 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. hESCs-derived Organoids Achieve Liver Zonation Features through LSEC Modulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Sandra Wiedenmann *Helmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-8160-0486
Markus Breunig *Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.ORCID http://orcid.org/0000-0002-2817-1974
Jessica MerkleDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Christine von ToerneResearch Unit Protein Science, Helmholtz Zentrum München, Munich, Germany.
Tihomir GeorgievHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.
Michel MoussusHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.
Lucas SchulteDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Thomas SeufferleinDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Michael SterrInstitute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
Heiko LickertInstitute of Diabetes and Regeneration Research, Helmholtz Zentrum München, Neuherberg, Germany.
Stephanie Ellen WeissingerInstitute for Pathology, Ulm University Hospital, Ulm, Germany.
Peter MöllerInstitute for Pathology, Ulm University Hospital, Ulm, Germany.
Stefanie M HauckResearch Unit Protein Science, Helmholtz Zentrum München, Munich, Germany.ORCID http://orcid.org/0000-0002-1630-6827
Meike HohwielerDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany. meike.hohwieler@uni-ulm.de.ORCID http://orcid.org/0000-0002-0640-0764
Alexander KlegerDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany. alexander.kleger@uni-ulm.de.ORCID http://orcid.org/0000-0003-0592-5232
Matthias MeierHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany. matthias.meier@helmholtz-muenchen.de.ORCID http://orcid.org/0000-0001-9455-4538

Funding

European Research Council 772646
6 · The paper itself

Abstract

Creating in vitro models of diseases of the pancreatic ductal compartment requires a comprehensive understanding of the developmental trajectories of pancreas-specific cell types. Here we report the single-cell characterization of the differentiation of pancreatic duct-like organoids (PDLOs) from human induced pluripotent stem cells (hiPSCs) on a microwell chip that facilitates the uniform aggregation and chemical induction of hiPSC-derived pancreatic progenitors. Using time-resolved single-cell transcriptional profiling and immunofluorescence imaging of the forming PDLOs, we identified differentiation routes from pancreatic progenitors through ductal intermediates to two types of mature duct-like cells and a few non-ductal cell types. PDLO subpopulations expressed either mucins or the cystic fibrosis transmembrane conductance regulator, and resembled human adult duct cells. We also used the chip to uncover ductal markers relevant to pancreatic carcinogenesis, and to establish PDLO co-cultures with stellate cells, which allowed for the study of epithelial-mesenchymal signalling. The PDLO microsystem could be used to establish patient-specific pancreatic duct models.

Indexed as

Cell DifferentiationLab-On-A-Chip DevicesAnimalsBiomarkers, TumorCellular ReprogrammingCystic Fibrosis Transmembrane Conductance RegulatorFilaminsHumansInduced Pluripotent Stem CellsMiceMice, Inbred NODMice, SCIDMucinsOrganoidsPancreatic DuctsPancreatic NeoplasmsBiomarkers, TumorCystic Fibrosis Transmembrane Conductance RegulatorFilaminsMucins

Identifiers

PMID34239116
PMCPMC7611572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.